CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • 30 Days of CRI Impact

    Throughout Cancer Immunotherapy Month in June we’ll be highlighting the 30 most important CRI-funded breakthroughs.

    June 1, 2018| Arthur N. Brodsky, PhD
  • AACR18 Day 2 Update: What’s Next for Cancer Immunotherapy?

    CRI scientists kicked off the opening plenary session at AACR18 and discussed several promising avenues of immunotherapy…

    April 16, 2018| CRI Staff
  • Recent FDA Announcements Herald Advances in Personalized Approaches Against Cancer

    Two tumor-profiling tests recently authorized by the FDA enable doctors to tailor their treatments more effectively to…

    December 22, 2017| Arthur N. Brodsky, PhD
  • NY-ESO-1 Identified as a Promising Vaccine Target in Ovarian Cancer Patients

    New study reveals effectiveness of immunotherapy vaccine against aggressive ovarian tumors.

    April 26, 2017| Arthur N. Brodsky, PhD
  • Kay Ellen and daughter Nicole

    Kay Ellen G’s Immunotherapy Story

    Ovarian Cancer I was much stronger than I thought. Kay Ellen’s Story Everyone needs an advocate sometimes….
    March 16, 2017| CRI Staff
  • Denise Zackman

    Denise Zackman’s Immunotherapy Story

    Ovarian Cancer |  Diagnosed 2007 You don’t think that you can just have cancer in your body and…
    March 15, 2017| CRI Staff
  • Barbara L

    Barbara L’s Immunotherapy Story

    Ovarian Cancer |  Diagnosed 2009 When we get the vaccine done, I think I’m only there about a…
    March 15, 2017| CRI Staff
  • ASCO 2016 Update: Immunotherapy Strategies for Women’s Cancers

    Improving immunotherapy for breast, ovarian, and gynecological cancer patients.

    June 6, 2016| Arthur N. Brodsky, PhD
  • ASCO 2015: Report from Day 4

    More cancers prove treatable with checkpoint blockade therapy. Today: kidney, bladder, and ovarian cancer.

    June 1, 2015| Matthew Tontonoz
Previous Page
1 2 3
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute